Best Grants for Free Clinics in Virgin Islands

Health systems, clinics, and research teams working on health care access and delivery in the Virgin Islands can seek upcoming NIH funding to improve integrated care for chronic pain and opioid use disorder. With a mission to advance evidence-based treatment, the National Institutes of Health will support implementation research, capacity building, and coordinated networks across diverse care settings.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Health Equity Fund

Help with healthcare costs for hemophilia (health equity fund)

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hepatitis C (HepC) Health Equity Fund

Help with healthcare costs for hepatitis C (health equity)

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type III (MPS III) Fund

Help with healthcare costs for mucopolysaccharidosis type III

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Fund

Help with healthcare costs for mucopolysaccharidosis type VII

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Health Equity Fund

Help with healthcare costs for mucopolysaccharidosis type VII (health equity)

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Free and safety-net clinics and other health care providers in the Virgin Islands conducting research on improving access to blood cancer care can apply for Leukemia & Lymphoma Society’s Equity in Access Research Grants. Awards up to US $2,500,000 support multi-year studies testing interventions to boost therapeutic cancer clinical trial participation, especially among underrepresented patients.

Nonprofit and governmental health organizations in the Virgin Islands can seek funding to deliver health services or public health education initiatives, including media and print outreach. Grants from Bennie & Martha Benjamin Foundation help community-based providers create brochures, ads, and other educational materials that promote health and track measurable benefits for Virgin Islands residents, with awards up to US $5,000.

Hospitals, public health clinics, and 501(c)(3) service providers in Virgin Islands can obtain funding for essential medical and health equipment and supplies where usual funding falls short. The Bennie & Martha Benjamin Foundation supports organizations with proven or well-planned health service delivery and clear methods to track benefits to the territory, including new initiatives improving health care access and delivery.

Virgin Islands free clinics and other eligible public entities or 501(c)(3) nonprofits can seek funding to develop school-based and school-linked oral health initiatives for children and families. CareQuest Institute for Oral Health offers up to US $125,000 for staff, community subgrants, policy and advocacy work, data, technology, and other project costs that improve oral health access and systems.

Health services research institutions and partners in the Virgin Islands can seek funding to study healthcare quality, patient safety, and delivery improvements through this program, with awards up to US $2,000,000. With a mission to advance health services research, the Agency for Healthcare Research and Quality supports projects across care settings that may benefit free clinics and safety-net providers.

Health services researchers and healthcare organizations in the Virgin Islands can seek funding to study healthcare quality, patient safety, and delivery improvements through the Agency for Healthcare Research and Quality. Grants from AHRQ help health care access and delivery programs with up to US $2,000,000 for projects in hospitals, clinics, home health, long-term care, and care transitions.

Health services researchers and eligible institutions in the Virgin Islands can apply for Agency for Healthcare Research and Quality small grants, with awards up to US $200,000 for projects. Funding supports studies on healthcare quality, patient safety, and delivery across settings, which may benefit free clinics focused on improving access and whole-person care.

Healthcare organizations improving patient safety through healthcare worker safety and well-being can apply for AHRQ’s Systems-Based Approaches R01, with awards up to US $2,000,000. Eligible entities in the Virgin Islands and other U.S. territories may support free clinic or safety-net care by advancing system-level patient care, occupational health, and healthcare delivery improvements.

The National Institutes of Health (NIH) is dedicated to advancing emergency care through the Strategies to Innovate Emergency Care Clinical Trials Network (SIREN). This initiative seeks to establish clinical enrollment hubs that will enhance the network's ability to conduct trials aimed at improving outcomes for patients experiencing neurological and cardiovascular emergencies. Although applications are not currently being accepted, this notice encourages potential applicants to prepare collaborative and impactful proposals.

Health care organizations and research teams working to study and improve diagnostic safety in ambulatory care may be eligible for funding, including in the Virgin Islands. Grants from the Agency for Healthcare Research and Quality help projects examine the incidence and contributing factors of diagnostic errors across outpatient, home health, and telehealth settings, with awards up to US $2,000,000.

Free and safety-net clinics and other ambulatory care providers in the Virgin Islands can seek funding to develop and test strategies that improve diagnostic safety and quality in outpatient settings. Focused on health care access and delivery, the Agency for Healthcare Research and Quality (AHRQ) offers up to US $2,000,000 for innovative ambulatory diagnostic interventions.

Healthcare systems and facilities improving health care access and delivery in the Virgin Islands can apply for Centers of Excellence in Healthcare Quality and Safety grants, with awards from US $3,500,000 - US $22,000,000. Grants from Dept. of Health & Human Services: Centers for Disease Control & Prevention support networks that detect, prevent, and respond to threats to patient and healthcare worker safety.

Research institutions and health systems working on integrated chronic pain and opioid use disorder care, including those serving the Virgin Islands, can apply for US Dept. of Health & Human Services: National Institutes of Health (NIH) funding to study health system–level solutions. Grants support collaborative care models, implementation strategies, and sustainable delivery of combined pain and OUD services.

The NIH is set to release a funding opportunity for pragmatic and implementation trials aimed at evaluating the effectiveness of interventions in real-world healthcare settings. This initiative encourages collaborations across various health systems to assess the effectiveness and feasibility of interventions. By focusing on commonly encountered conditions in everyday clinical care, the trials aim to provide actionable insights for patients, clinicians, and policymakers. Interested investigators are encouraged to start developing their project proposals.

Health care and research organizations addressing opioid use disorder and health care access can receive support in the Virgin Islands and other U.S. territories to test linkage-to-care strategies. The Centers for Disease Control & Prevention funds investigator-initiated projects that partner with public health entities and local clinical champions to improve overdose prevention and real-world care systems, with awards up to US $550,000.

The Telehealth Nutrition Services Network Grant Program, funded by the Health Resources and Services Administration, aims to enhance access to quality health care through innovative telehealth nutrition services. This program focuses on preventing and managing chronic diseases by leveraging telehealth technology, ensuring that individuals receive essential nutrition guidance remotely. With a commitment to improving health outcomes, this initiative will significantly benefit communities seeking better access to healthcare resources.

The FY 2027 Service Area Competition (SAC) funding aims to enhance healthcare access in underserved communities across the U.S. by providing grants for comprehensive primary and preventive health services. This initiative addresses essential health needs through competitive funding opportunities, ensuring that health centers can effectively serve their designated areas. Additional service areas may be announced as needed if current centers are unable to continue their operations, thus maintaining service continuity.

The FY 2027 Service Area Competition (SAC) aims to enhance health services in underserved communities across the U.S. and its territories. This funding opportunity supports comprehensive preventive and primary health care delivery. Each SAC announcement details service areas available for competition, with potential additional areas announced throughout the year. This initiative is crucial for ensuring continuous access to quality health care for vulnerable populations.

The FY 2027 Service Area Competition (SAC) aims to enhance health services in underserved communities across the U.S. by providing grants for comprehensive primary and preventive care. This initiative will support health centers in delivering high-quality services, addressing the needs of populations that face barriers to care. Each funding opportunity will specify service areas available for competition, ensuring effective resource allocation to improve community health outcomes.

The FY 2027 Service Area Competition (SAC) funding aims to enhance health services in underserved communities across the U.S. by providing grants for comprehensive preventive and primary health care. The initiative supports health centers in delivering essential services, ensuring that vulnerable populations receive the care they need. Service areas for competition are announced periodically, and additional areas may be added if existing centers are unable to continue their services.

The FY 2027 State and Regional Primary Care Association (PCA) Cooperative Agreements aim to enhance the technical assistance provided to Health Center Program award recipients and look-alikes. This initiative focuses on improving access to preventive and primary health care, managing chronic diseases, and ensuring a capable health center workforce. By implementing value-based care strategies and leveraging data for operational improvements, the program seeks to support the health of vulnerable communities effectively.